Skip to main content
Fig. 6 | BMC Biotechnology

Fig. 6

From: Screening of miRNAs in plasma as a diagnostic biomarker for cardiac disease based on optimization of extraction and qRT-PCR condition assay through amplification efficiency

Fig. 6

Relative levels of miRNA-16, miRNA-21, miRNA-132, miRNA-155, and miRNA-499 analyzed by qRT-PCR in four AMI patients vs three controls. Relative level of each miRNA was obtained by normalization of Cel-miRNA-39-1, and horizontal middle line in each data set represents mean. Mann–Whitney test was performed comparing AMI patients with control miRNAs levels. The P values was 0.2286 for miRNA-16, P = 0.1143 for miRNA-21, 0.8571 for miRNA-132, 0.4000 for miRNA-155 and 0.0571 for miRNA-499

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us